REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer

S Songul Kucukcelebi F Freek R. van ‘t Land S Sjoerd H. van der Burg F Ferry A. L. M. Eskens M Marjolein Y. V. Homs M Marcella Willemsen A Anne Onrust-van Schoonhoven N Nina E. M. Rozendaal A Amine Fellah D Disha Vadgama M Miranda Moskie K Koen Bezemer M Michail Doukas C Casper W. F. van Eijck R Ralph Stadhouders (Pulmonary Medicine Department, Erasmus University Medical Center) J Judith de Vos-Geelen A Aniek E. van Diepen I Ilona Enninga R Rob Meijer S Sumeet V. Ambarkhane P Peter Ellmark J Joachim G. J. V. Aerts C Christianne Groeneveldt C Casper H. J. van Eijck

Article Details

Volume / Issue Vol. 16, Issue 1
Published November 28, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (24)

S

Songul Kucukcelebi

F

Freek R. van ‘t Land

S

Sjoerd H. van der Burg

F

Ferry A. L. M. Eskens

M

Marjolein Y. V. Homs

M

Marcella Willemsen

A

Anne Onrust-van Schoonhoven

N

Nina E. M. Rozendaal

A

Amine Fellah

D

Disha Vadgama

M

Miranda Moskie

K

Koen Bezemer

M

Michail Doukas

C

Casper W. F. van Eijck

R

Ralph Stadhouders

Pulmonary Medicine Department, Erasmus University Medical Center

J

Judith de Vos-Geelen

A

Aniek E. van Diepen

I

Ilona Enninga

R

Rob Meijer

S

Sumeet V. Ambarkhane

P

Peter Ellmark

J

Joachim G. J. V. Aerts

C

Christianne Groeneveldt

C

Casper H. J. van Eijck